RSV pneumonia, a community-acquired infection in adults

Lancet

Volumn 349, Issue 9046, 1997, Pages 149-150

  La Montagne, J R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; VACCINE;

ADULT; ANTIBODY TITER; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SHORT SURVEY; SIDE EFFECT; UNITED STATES; VIRUS PNEUMONIA;

EID: 0031018851     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60974-9     Document Type: Note

References (7)

1. Collins PL, McIntosh K, Chanock RM. Respiratory syncytial virus. In: BN Fields, DM Knipe, PM Howley eds. Fields virology, 3rd ed. Vol 1. 1995. 1313–51.
2. WP Glezen LH Taber AI Frank JA Kasel Risk of primary infection and reinfection with respiratory synctial virus Am J Dis Child 140 1986 543 546
3. AR Falsey CK Cunningham WH Barker Respiratory synctial virus and influenza A infections in the hospitalized elderly J Infect Dis 172 1995 389 394
4. JR Groothuis EAF Simoes MJ Levin Prophylactic administration of respiratory synctial virus immune globulin to high-risk infants and young children N Engl J Med 329 1993 1524 1530
5. VG Hemming W Rodriguez HW Kim Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children Antimicrob Age Chemother 31 1987 1882 1886
6. CB Hall JT McBride EE Walsh Aerosolized ribavirin treatment of infants with respiratory synctial virus infection N Engl J Med 308 1983 1443 1447
7. SF Dowell LJ Anderson HE Gary Jr Respiratory syncytial virus is an important cause of community-acquired lower respiratory infections among hospitalized adults J Infect Dis 174 1996 456 462